Automation combined with on-line monitoring during the cell expansion step can bring cell therapy manufacturing efficiencies and enable increased patient accessibility and safety
908 Devices...
LAITEK, a long-time and leading provider of medical imaging migration services announces a new Advanced Hybrid Migration service that lowers the cost of migrating...
Tempus, a leader in artificial intelligence and precision medicine, announced xF Monitor – a new circulating tumor DNA (ctDNA) assay for research use only,...
Telesis Bio Inc., a leader in automated multi-omic and synthetic biology solutions, announced the commercial release of its BioXp® De novo Cloning and Amplification...
QIAGEN and Element Biosciences, Inc. announced a strategic partnership to offer comprehensive next-generation sequencing (NGS) workflows for the Element AVITI™ System, an innovative sequencing...
New data supports the potential role of Artificial Intelligence (AI) in predicting patients’ response to immunotherapies in advance of their treatment.
GE HealthCare’s Artificial Intelligence...
Medidata to announce latest innovations to accelerate drug and device development to bring treatments to patients sooner
Medidata, a Dassault Systèmes company and leading provider...
Powerful and comprehensive health monitoring platform now offers FDA-cleared biomarkers for pulse and respiratory rate
Empatica, a digital health and AI company developing medical-grade wearables...
Multi-year collaboration will enable development of complex, cutting-edge cell therapies and armoring technologies for solid tumor targets
Generate:Biomedicines and Roswell Park Comprehensive Cancer Center announced...
TSO 500 ctDNA Version 2 delivers faster turnaround time, greater analytical sensitivity, more streamlined workflow, further enabling precision medicine.
Illumina Inc., a global leader in...